On February 26, Groupon Inc. (NASDAQ:GRPN) announced the start of its Taste of Groupon event that brings together restaurants across the nation to entice people to eat out, but with a social purpose. As part of the program, Groupon will donate a meal to Feeding America for every food or drink offers consumer engage through the deal. Groupon’s taste buds for the event range from casual burger bars to high-end French restaurants. On Friday shares of Groupon, Inc. (NASDAQ:GRPN) closed at $8.18. Company’s sales growth for last 5 years was 194.10% and EPS growth for next 5 years is recorded as 39.00%.
On February 23, it was reported that, Itau Unibanco Holding SA (ADR) (NYSE:ITUB) reorganized its executive committee as Chief Executive Officer Roberto Setubal prepares for his succession in about two years. The goal is “to make the transition to the future in a smooth and safe way and address the most immediate challenges of the bank,” Setubal said Monday in an e-mailed statement. “Priorities remain efficiency and simplification.” Itau Unibanco Holding SA (ADR) (NYSE:ITUB) in last trading activity advanced 0.55% to close at $12.78. Company weekly performance is 2.49% while its quarterly performance stands at -15.53%. Itau Unibanco Holding SA (ADR) (NYSE:ITUB) is -28.90% away from its 52 week high.
Northrim BanCorp, Inc. (NASDAQ:NRIM) announced that the Board of Directors declared its regular quarterly cash dividend of $0.18 per share. The dividend will be paid March 20, 2015, to shareholders of record as of the close of business on March 12, 2015. On last trading day Northrim Bancorp Inc. (NASDAQ:NRIM) advanced 1.24% to close at $23.65. Its volatility for the week is 2.75% while volatility for the month is 2.45%. NRIM’s sales growth for past 5 years was 0.60% and its EPS growth for past 5 years was 16.20%. Northrim Bancorp Inc. (NASDAQ:NRIM) monthly performance is 10.77%.
Gilead Sciences Inc. (NASDAQ:GILD), announced detailed 48-week results from two phase 3 studies (Studies 104 and 111) evaluating its investigational once-daily single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults. Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity fell -0.63% to close at $103.53. Company weekly performance is 0.90% while its quarterly performance stands at 2.39%. Gilead Sciences Inc. (NASDAQ:GILD) is -11.38% away from its 52 week high.
Vetr lowered shares of Pfizer Inc (NYSE:PFE) from a hold rating to a sell rating in a research report released on Thursday morning. Vetrcurrently has $35.10 price objective on the stock. On last trading day Pfizer Inc. (NYSE:PFE) fell -0.78% to close at $34.32. Its volatility for the week is 1.34% while volatility for the month is 1.59%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is 8.37%.